Results 41 to 50 of about 8,207,494 (286)

The Nurse’s Role in Preventing Ventilator-Associated Pneumonia

open access: yesBatı Karadeniz Tıp Dergisi, 2021
Ventilator-associated pneumonia(VAP) is an important condition constituting the half of the hospitaloriginatedpneumonia cases. The ventilator-associated pneumonia can result from microorganisms inthe patient’s own flora, visitors, hospital staff, other ...
Canan Kaş Güner, Sevinç Kutlutürkan
doaj   +1 more source

Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study [PDF]

open access: yes, 2013
Background: Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection. Studies of biomarker associations with bacterial pneumonia risk in treated HIV-infected patients do
Kunisaki, KM   +39 more
core   +1 more source

Incidence and Outcome of Ventilator Associated Pneumonia in ICU of a Tertiary Care Hospital in Nepal

open access: yesJournal of Nepal Medical Association, 2017
Introduction: Ventilator associated pneumonia is an important intensive care unit acquired infection in mechanically ventilated patients. Early and correct diagnosis of Ventilator associated pneumonia is difficult but is an urgent challenge for an ...
Deebya Raj Mishra   +2 more
doaj   +1 more source

Accurate measurement of ventilator length of stay and ventilator days for use in assessing patient safety and ventilator associated events

open access: yesJournal of Mechanical Ventilation, 2020
Objective: Accurate measurements of ventilator length of stay are important for quality measures and mandated by Centers of Disease Control for reporting ventilator associated events.
Kimiyo Yamasaki   +2 more
doaj   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Características clínicas, epidemiológicas y evolución de la neumonía nosocomial severa en la unidad de cuidados intensivos [PDF]

open access: yesHorizonte Médico, 2016
Objetives: To describe the clinical and epidemiological characteristics, evolution and to identify mortality factors associated in patients with SNP.
Edwin Albino H.   +2 more
doaj  

Evaluation of the Effects of Probiotics on Incidence of Ventilator-Associated Pneumonia in Patients Hospitalized in Intensive Care Unit

open access: yesمجله دانشکده پزشکی اصفهان, 2019
Background: Ventilator-associated pneumonia (VAP) is an important hospital infection. Supportive treatments along with antibiotic therapies play a pivotal role in VAP treatments.
Mohammad Golparvar, Fereshteh Raoufi
doaj   +1 more source

Dynamically Actuated Reconfigurable Topographical Surface Enables Active Control of Implant‐Associated Infections

open access: yesAdvanced Functional Materials, EarlyView.
A dynamically actuated reconfigurable topographical surface (DARTS) integrates contact‐mediated bactericidal nanotopography with programmable mechanical actuation to actively disrupt bacterial biofilms. Dynamic surface reconfiguration enhances bacterial killing and suppresses implant‐associated infections in vivo, providing a new strategy for active ...
Mohammad Asadi Tokmedash   +4 more
wiley   +1 more source

Antibiotics for ventilator-associated pneumonia [PDF]

open access: yesCochrane Database of Systematic Reviews, 2016
Ventilator-associated pneumonia (VAP) is a significant cause of morbidity and mortality, complicating the medical course of approximately 10% of mechanically-ventilated patients, with an estimated attributable mortality of 13%. To treat VAP empirically, the American Thoracic Society currently recommends antibiotic therapy based on the patients' risk of
Arthur, Lauren E   +4 more
openaire   +2 more sources

Hydrogels Augmented With Artificial Sweeteners can Inhibit Multidrug‐Resistant Acinetobacter baumannii Growth and Biofilm Formation While Demonstrating Safety in Pre‐Clinical Pilot Human Trials

open access: yesAdvanced Healthcare Materials, EarlyView.
Using PVA–borax hydrogels as carriers for off‐the‐shelf artificial sweeteners to fight multidrug‐resistant A. baumannii. These soft, biocompatible hydrogels rapidly reduce bacterial viability within multidrug‐resistant A. baumannii biofilms by more than 99% within one hour and sustain antimicrobial activity over time, while demonstrating safety in both
Jie Han   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy